The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Translational Research Grant
The 2020 Pancreatic Cancer Action Network Translational Research Grant will fund high priority pancreatic cancer research that is poised for important translational next steps to help move scientific discovery to application in patients. PanCAN has partnered with the Celgene Corporation to accelerate the development of novel therapies by establishing strong relationships between academia and industry through research grants. Funded projects will benefit from industry input and insight, leading to an accelerated translation into a therapeutic product. The grant provides $500,000 over two years, with the potential to expand to a third year with additional funds. Projects will be strategically supported by both PanCAN and Celgene to facilitate progress and increase the likelihood of success.
To be eligible for a Translational Research Grant, the research project should aim to identify novel targets and approaches to the treatment of pancreatic cancer or understand and circumvent treatment resistance. Of particular interest are research projects that fall into at least one of these three areas of research: a) Immune context and tumor microenvironment interactions, (b) Regulators of pathogenesis, progression and metabolism, with particular interest in epigenetic mechanisms and (c) Transcriptional networks essential for viability and maintenance of malignant phenotype.
Deadline: Dec 6, 2019
• Applicants must have a doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD or equivalent) in the biomedical sciences or in a field applicable to health science research and not currently be a candidate for a further doctoral degree. • The contact principal investigator (contact PI) must be affiliated with an accredited academic, medical or research institution. International institutions are included. • One co-PI may be named. The co-PI should be affiliated with any academic, medical or research institution, including international institutions. The co-PI must have a doctoral degree. Researchers can be a contact PI on one application and may be identified as a co-PI on a second application. • Employees or subcontractors of a government entity are not eligible to be a PI or to receive funds from the grant, but can be included as a collaborator or project investigator.
The Translational Research Grant provides $500,000 over two years. Funds can be used for salaries and benefits, laboratory supplies, equipment (maximum of 10 percent of total grant), subject trial costs and publication charges for manuscripts that pertain directly to the proposed project. Expenses for regular communications can be included if a co-PI is located at a different institution.